Search for: "Line v. Line" Results 5361 - 5380 of 45,548
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
20 Jan 2022, 3:30 am by Mary Ziegler
Sara Matthiesen, Reproduction Reconceived: Family Making and the Limits of Choice after Roe v. [read post]
20 Jan 2022, 3:00 am by Phil Dixon
Findings of fact failed to resolve material conflicts in the evidence from suppression hearing; denial of motion to suppress vacated and remanded for new findings State v. [read post]
19 Jan 2022, 6:02 pm by Josh Blackman
Indeed, remember Chief Justice Roberts tried to pawn off Roe's viability line as dicta? [read post]
18 Jan 2022, 5:01 am by Eugene Volokh
But whatever the right bottom line, we should acknowledge the cost of such a safety-first approach.[9] To be sure, when our activities cause hazards to others, we often have to cease those activities, at least if the magnitude of the hazard is seen as "unreasonable. [read post]
18 Jan 2022, 1:41 am by rainey Reitman
Maryland Turns 35, But Its Health Is Declining, EFF Carpenter v. [read post]
18 Jan 2022, 1:41 am by rainey Reitman
Podcast Episode 108 Your friends, your medical concerns, your political ideology— financial transactions tell the story of your life in intimate details. [read post]
17 Jan 2022, 4:15 pm by INFORRM
On, 17 January 2002, the second day of the libel trial in the case of Banks v Cadwalladr, Mrs Justice Steyn heard evidence from both the claimant and the defendant. [read post]
17 Jan 2022, 1:29 am by Peter Mahler
” Spatz v Ridge Lea Associates, LLC, a 2003 decision by the Appellate Division, Fourth Department, in which it reversed the lower court’s order denying a motion to compel arbitration in an action for judicial dissolution of an LLC. [read post]
17 Jan 2022, 1:08 am by Rose Hughes
 Further readingBayer v Teva: Drug formulation patent found "the result of standard and routine considerations" ([2021] EWHC 2690 (Pat)) (28 Nov 2021)Second medical use dosage regimen claim successfully traverses both insufficiency and "obvious-to-try" attacks (T 0799/16) (8 March 2021)Canadian Federal Court considers whether Teva's COPAXONE second medical use patents were obvious-to-try (Teva v Pharmascience) (25 Jan 2021)Supreme Court… [read post]